Tissue engineering: the ultimate solution to regenerate human tissue
Restoring What's Lost: Tissue Engineering for a Brighter Future
Human tissue loss can occur at any point in our lives due to various reasons such as vascular diseases, sudden trauma, or cancer. Vascular diseases encompass conditions like diabetes, peripheral arterial disease (PAD), and blood clots, which can impede blood flow to limbs and...
Claro has now joined forces with Regemat 3D (a biotech company pioneer in the design and development of customized 3D bioprinters and bioreactors for research in the regenerative medicine field), which will now distribute Claro’s BG800 that was developed for extrusion-based bioprinters.
Claro acknowledges that bioprinting will help periodontal therapy advance
Periodontal (gum) disease: an annual cost estimated at 79 billion euros in Europe Periodontal (gum) disease is extremely common. Severe periodontal diseases are found in 5–20% of middle-aged (35–44 years) adults in Europe, and up to 40% of older people (65–74 years). Diseases of the mouth are an expensive burden to health care services.
